Medicine and Dentistry
6 O Methylguanine
50%
Adverse Event
7%
Age Groups
16%
Analysis
50%
Biological Marker
50%
Brachytherapy
50%
Diagnosis
40%
Differentiation
50%
Dose Calculation
12%
Dose-Volume Histogram
12%
Dosimetry
50%
Edema
25%
Ganglioglioma
21%
Gland
37%
Glioblastoma
100%
Heterozygosity
50%
Implant
50%
Magnetic Resonance Imaging
50%
Magnetic Resonance Imaging
12%
Marker
16%
Molecular Marker
16%
Multiple Linear Regression Analysis
25%
Neoplasm
7%
Patient
53%
Side Effect
14%
Specimen
16%
Therapeutic Procedure
7%
X-Ray Imaging
12%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
12%
Genetic Marker
16%
Isocitrate Dehydrogenase
50%
Loss of Heterozygosity
50%
Methylation
33%
Molecular Biology
16%
O-6-Methylguanine-DNA Methyltransferase
50%
Phase I Trials
12%
Phase II Trials
12%
Prospective Study
25%
Neuroscience
6-O-Methylguanine
50%
Brain
50%
Chemotherapy
7%
Glioblastoma Multiforme
66%
Glioma
25%
Metastasis
50%
